Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patch deconvolution for Fourier light-field microscopy.

Biophysical journal·2026
Same author

Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell Carcinoma.

Cancers·2025
Same author

A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance.

BMC biology·2025
Same author

The nucleosome remodeling and deacetylase-SWItch/sucrose non-fermentable antagonism regulates the coordinated activation of epithelial-to-mesenchymal transition and inflammation in oral cancer.

Journal of the National Cancer Institute·2025
Same author

Highlight: microfluidic devices for cancer metastasis studies.

In vitro models·2025
Same author

Organ-on-a-Chip Technologies Network special issue editorial.

In vitro models·2025

Related Experiment Video

Updated: Feb 25, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K

Reprogramming to developmental plasticity in cancer stem cells.

Caitlin O'Brien-Ball1, Adrian Biddle1

  • 1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.

Developmental Biology
|August 5, 2017
PubMed
Summary
This summary is machine-generated.

Cellular plasticity, the ability to change cell type, is key in development and cancer. Understanding how cancer cells reactivate developmental plasticity mechanisms is crucial for new therapies targeting tumor growth and metastasis.

Keywords:
CancerDevelopmentEMTPlasticityReprogrammingStem

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Cancer Biology

Background:

  • Phenotypic plasticity, the ability of cells to differentiate into multiple lineages, is crucial during development and in adult stem cells.
  • This plasticity can be reactivated in cancer cells, driving tumor progression, metastasis, and therapeutic resistance.
  • The epithelial-to-mesenchymal transition (EMT) is a key mechanism of phenotypic plasticity observed in both normal and cancerous cells.

Purpose of the Study:

  • To explore the role of developmental mechanisms of phenotypic plasticity in cancer.
  • To identify how reactivated plasticity contributes to cancer stem cell phenotypes, survival, and metastasis.
  • To investigate potential therapeutic strategies targeting these developmental plasticity mechanisms in cancer.

Main Methods:

  • Review of existing literature on cellular plasticity, epigenetics, metabolism, and cancer biology.
  • Analysis of studies investigating the epithelial-to-mesenchymal transition (EMT) in normal and cancerous contexts.
  • Examination of research on cancer stem cells (CSCs) and their relationship to developmental plasticity.

Main Results:

  • Phenotypic plasticity, involving epigenetic and metabolic changes, is reactivated in cancer cells.
  • This reactivation enables the acquisition of cancer stem cell (CSC) phenotypes, enhancing survival and metastasis.
  • Plasticity may also represent vulnerabilities that can be exploited therapeutically.

Conclusions:

  • Targeting reactivated developmental mechanisms in cancer holds promise for reducing tumor growth and metastasis.
  • Understanding plasticity is key to overcoming therapeutic resistance in cancer.
  • Further research is needed to identify and target these specific developmental pathways in cancer treatment.